top of page

Search Results

Results found for "mentorship in science"

  • When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission

    Watch Episode 170 Why We’re Here What if your own body pushed you into science? For Dr. The Value of Lived Experience in Science What makes Serafini’s trajectory so compelling isn’t just his Takeaway Science isn’t always about curiosity. Sometimes, it’s about necessity. Dr.

  • How GPCR Collaboration Built an Innovation Engine

    But at Monash Institute of Pharmaceutical Sciences, a different idea took root: what if collaboration This wasn’t just a clever idea on paper — it changed how science happened, day to day. Most GPCR discoveries aren’t blocked by science — they’re blocked by structures that make sharing hard collaborations and industry partnerships take root Today  — Model continues to produce high-impact GPCR science GPCR science thrives in complexity — meaning no single lab or company can do it alone.

  • Signals in Motion: Pain, Metabolism & Terry’s Corner

    Maria Majellaro shares her story of innovation and listening-driven science.   efficacy, and design smarter GPCR pharmacology screens, anchored in real-world lessons and cutting-edge science Stay curious, stay connected, because the future of GPCR science is being written pathway by pathway.

  • From GPCR Data Chaos to Decisive Action

    Most teams don’t stall because the science is weak. They stall because the data becomes a mess. The Hidden Cost of Good Science Without Systems I’ve seen this pattern again and again—across academia Strong science. Promising data. But no systems to turn it into momentum. drgpcr/yamina-corner Or explore how we can work together: 👉 Yamina.org 🔑 Key Takeaways ✅ Even strong science

  • The One Reason Why Biotech Startups Fail More Often Than They Should

    The difference between surviving and failing in biotech is rarely science. Science evolves in parallel with regulatory funding pressure and team growth.   Not because the science stops working, but because the organization stops knowing what matters most right Strategy creates a shared filter that connects science execution and business reality. ✅ At its core, Without it, even strong science slowly loses direction. 👉 Understanding why biotech startups fail  is

  • From Lab Bench to Boardroom: The Unexpected Path of a Medicinal Chemist

    It began in Bari, Italy, with a love for science nurtured by her father and fueled by childhood cartoons without the delays and frustrations that often plague probe development. 👉 Learn more about Celtarys’ science-driven

  • A Note from Yamina: Building the Next Chapter of Dr. GPCR

    GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery These resources continue to bring the latest in GPCR science and industry updates to thousands across GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR Foundry: Science Meets Execution The Foundry is where we bring together biotech innovators, Venture the podcast and blog to our Premium ecosystem and Foundry initiatives, our mission is to advance GPCR science

  • New Podcast, Sweet Structures & $2.2B GPCR Moves

    Scroll down for the science, the strategy, and the sweet stuff 🍬 Dr. Wear Your Science – Dr. GPCR merch is here! Show off your receptor pride and support the mission.

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    signaling, and inflammation-linked GPCRs — and curated roles in computational and membrane protein science scientists Influence   the curriculum with your topic suggestions Weekly new releases  to stay ahead of the science new episodes will drop bi-weekly on Wednesday mornings  — giving you mid-week insights that connect science It’s about how Revvity turns deep science into tools that endure. Read the full story➤ Why Dr.

  • GPCR Happy Hour – Boston, Sept 2025

    Scientists, investors, and CRO professionals fly in from around the world, while Boston’s own vibrant life sciences Our mission is simple: bridge science and industry  by connecting researchers, biotech, CROs, and pharma chance to be part of the conversations that will ripple far beyond Boston. ✨ GPCR Happy Hour: Where science

  • From Pipettes to Platforms: The Evolution of GPCR Research

    And it’s a reminder that the way we do science today wasn’t inevitable — it was engineered, learned, Luck, and the Lab The episode isn’t just about technology — it’s also about how careers are shaped in science Technology accelerates science, but people direct it.

  • The Hidden Cost of Ambition in Biotech Leadership

    Not poor science. But loss of disciplined prioritization . If the science supports it, why not pursue it? Not because the science is flawed, but because the trajectory is less precise. 👉 The important distinction ✅ It aligns science, capital allocation, and communication into one coherent direction.

  • Why Intracellular Drugs May Hold the Key to GPCR Therapeutics

    Kenakin walks you through the science, the data, and the practical methods for making it happen.   Unlock “Intracellular Drugs” Now Only in Terry’s Corner   Why Terry’s Corner In a world where GPCR science Stay ahead with The Kenakin Brief  — a concise, science‑first email update with the latest insights in

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    If you’re building tools or careers in GPCR science, this is your playbook. Product development isn’t just about science. you’re launching a tool, starting a biotech, or running an academic lab—your mindset, not just your science

  • Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault

    insights from molecular dynamics, biased signaling, and allosteric modulation, this session lays bare the science

  • Pharmacology Isn't What You Think—It's So Much More

    Uniqueness of Pharmacology in Drug Discovery,” Terry Kenakin explains why pharmacology isn’t a clean-cut science—it

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    GPCR , the global nonprofit platform dedicated to advancing GPCR science through education, community and innovate in the world of G protein-coupled receptors . 🔗 About Revvity Revvity  is a global life sciences

  • The Moment Biotech Founders Realize the Money Is Gone

    . 👉 The real issue begins earlier, at a point where the company is still operating, the science is progressing In early-stage biotech, progress is measured through science. Experiments advance. Data improves. Hiring decisions feel justified because the science is moving. The science continues, but the intent behind decisions changes.

  • Ever Wondered How Drugs Are Discovered?

    foundational-level  lesson, Terry unpacks the real-life process behind discovering new drugs, breaking down the science

  • Accelerating GPCR Drug Discovery

    challenges: missed opportunities, misaligned systems, and promising programs stalling despite strong science Here's how I bring a fresh perspective: Biology-First, Data-Driven Strategy:  I help you focus on the science

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    For instance, Heydenreich et al. (2023) developed a data science framework that combined mutagenesis Deep mutational scanning: a new style of protein science. Nature Methods , 11 (8), 801-807. Science , 382 (6677), eadh1859. Kosar, M., Sarott, R. C., Sykes, D. A., Viray, A. E., Vitale, R. ACS Central Science , 10 (5), 956-968. Nguyen, A. T., Baltos, J.-A., Thomas, T., Nguyen, T.

  • Beyond HEK293 — Terry HĂ©bert on iPSC-Derived GPCR Models, Live April 16,

    What draws me to this meeting is not just the science on the program, but the conversations that happen What Members Say The scientists in this community hold teaching to the same standard they hold the science

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    Sometimes, science rewards the bold. _________________ Keyword Cloud: GPCR online course, early-career

  • How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)

    Terry Kenakin to elevate your science and sharpen your calls. It’s built for the GPCR community—by people who live the science—so you spend less time sifting and more masterful teacher and communicator." — DrGPCR University Attendee Everything you need to master GPCR science

  • Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right

    Terry Kenakin to elevate your science and sharpen your decisions. Career opportunities:  Research Assistant; Postdoctoral Associate; Senior Scientist, Data Science—curated to turn ambiguous signals into confident, defensible decisions—and join a community designed to move science

  • Fentanyl and Xylazine: Why Breathing Fails in Overdose

    Watch Episode 172 The Bigger Picture: GPCR Science Meets Public Health At its core, Catherine Demery’ In other words, this is GPCR science with immediate, life-or-death consequences. The question now is whether science and public health can keep up.”

  • From Ox Liver to AI: How the History of Pharmacology Shapes Its Future

    👉 Join Terry’s Corner, your essential launchpad into the world of therapeutic science Unlock "The History

  • The Chemistry of Confidence: Aha Moments That Shape Scientific Careers

    Watch Episode 168 Success in science is rarely linear.

  • Lab Leadership Without Ego: How Sokhom Pin Built the Happiest Team at Alkermes

    Watch Episode 169 Leadership in science isn't just about results, it's about people.

  • Allosteric Binding Demystified: Smarter GPCR Drug Discovery

    decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not because of bad science Each week, you gain curated intelligence across science, careers, and strategy: Deep-dive expert lectures

bottom of page